Citicoline and DHA supplement for glaucoma patients
Part of Eyes & vision clinical trials.
This trial tests whether a dietary supplement (DHA + citicoline) can help protect vision in people with glaucoma. You may qualify if you have confirmed glaucoma in at least one eye and are between 50 and 75 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glaucoma in at least one eye, with damage seen on eye scans (OCT) and vision field tests
- You have had at least 4 reliable vision field tests before joining
- You are between 50 and 75 years old
- You have not used any vitamin or supplement in the past month
- You have not had eye surgery or laser treatment in the last 3 months
- Your vision field test score (MD) is between -3 and -20 decibels
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether NAD precursor supplements can improve nerve health and vision in people with glaucoma. If you have glaucoma with mild to moderate vision loss, this study may help understand if these supplements could protect your optic nerve.
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
This study tests whether metformin can slow damage to the optic nerve in people with glaucoma. It uses eye scans and vision tests to look for changes over time, aiming to help preserve sight.
This trial tests whether a home-based exercise program can lower eye pressure and protect the optic nerve in people with glaucoma. It is designed for patients whose eye pressure is already controlled by medication.
This trial studies whether nicotinamide (a form of vitamin B3/niacin) can slow or affect glaucoma progression. You may be eligible if you have newly diagnosed, untreated glaucoma or if you have treated glaucoma with measurable visual field changes.
This study looks at whether a common class of glaucoma eye drops (called prostaglandin analogues) can protect the nerve cells in the back of the eye. It may help people with certain types of glaucoma who have been stable on one type of eye drop for at least 3 years.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.